KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Cash & Current Investments: 2009-2025

Historic Cash & Current Investments for Thermo Fisher Scientific (TMO) over the last 17 years, with Sep 2025 value amounting to $3.5 billion.

  • Thermo Fisher Scientific's Cash & Current Investments fell 46.64% to $3.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $21.5 billion, marking a year-over-year decrease of 30.34%. This contributed to the annual value of $5.6 billion for FY2024, which is 31.06% down from last year.
  • As of Q3 2025, Thermo Fisher Scientific's Cash & Current Investments stood at $3.5 billion, which was down 44.51% from $6.4 billion recorded in Q2 2025.
  • Thermo Fisher Scientific's Cash & Current Investments' 5-year high stood at $12.0 billion during Q4 2021, with a 5-year trough of $1.9 billion in Q3 2022.
  • Over the past 3 years, Thermo Fisher Scientific's median Cash & Current Investments value was $6.2 billion (recorded in 2023), while the average stood at $5.9 billion.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first crashed by 75.73% in 2022, then spiked by 181.62% in 2024.
  • Thermo Fisher Scientific's Cash & Current Investments (Quarterly) stood at $4.5 billion in 2021, then spiked by 90.40% to $8.5 billion in 2022, then decreased by 5.21% to $8.1 billion in 2023, then tumbled by 31.06% to $5.6 billion in 2024, then slumped by 46.64% to $3.5 billion in 2025.
  • Its Cash & Current Investments stands at $3.5 billion for Q3 2025, versus $6.4 billion for Q2 2025 and $5.9 billion for Q1 2025.